APA (7th ed.) Citation

E, B., M, G., D, B., E, B., JG, K., VP, R., . . . R, A. (2020). Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors. Science translational medicine, 12(541), . https://doi.org/10.1126/scitranslmed.aaz2481

Chicago Style (17th ed.) Citation

E, Banks, et al. "Discovery and Pharmacological Characterization of AZD3229, a Potent KIT/PDGFRα Inhibitor for Treatment of Gastrointestinal Stromal Tumors." Science Translational Medicine 12, no. 541 (2020). https://doi.org/10.1126/scitranslmed.aaz2481.

MLA (9th ed.) Citation

E, Banks, et al. "Discovery and Pharmacological Characterization of AZD3229, a Potent KIT/PDGFRα Inhibitor for Treatment of Gastrointestinal Stromal Tumors." Science Translational Medicine, vol. 12, no. 541, 2020, https://doi.org/10.1126/scitranslmed.aaz2481.